Reading the Topical Steroid Strength Chart

What the strength chart actually ranks

The chart sorts topical corticosteroids by potency — how strongly they calm inflammation in the skin — not by how thick or greasy they feel. In the United States the scale has seven classes. Class 1 is the superpotent group; Class 7 is the least potent. A Class 1 steroid can be many times more powerful than the hydrocortisone sold over the counter, which sits near the bottom of the scale.

Potency is how strongly a steroid suppresses skin inflammation, judged by how much it blanches the skin — not how strong the cream feels going on.

Potency is ranked by a skin-blanching, or vasoconstrictor, test: the more a steroid narrows the tiny vessels just under the surface, the higher its class. Some countries fold the same idea into four bands — mild, moderate, potent, and very potent — but the logic is identical. The class number is a shorthand for two things at once: how much inflammation the steroid is expected to control, and how much risk it carries if it lands in the wrong place. Familiar names spread across the whole scale. Clobetasol and halobetasol sit at the superpotent top. Triamcinolone, mometasone, fluticasone, and betamethasone valerate run through the middle. Desonide and alclometasone sit low. Plain hydrocortisone anchors the gentle end. Reading a chart, then, is less about memorizing names than about knowing which end of it a given tube belongs to.

Why the same drug shows up at different strengths

Three things set a steroid's place on the chart: the molecule itself, how concentrated it is, and the base it is carried in. The base surprises people the most. The same active steroid is stronger as an ointment than as a cream, and stronger as a cream than as a lotion or foam, because a greasy ointment seals the drug against the skin and helps it soak in.

That is why one drug can appear at more than one spot on a chart. A single steroid, packaged in a richer base or at a higher concentration, climbs a class or two. Anything that traps the cream against the skin raises its effective strength further: plastic-wrap occlusion, a thick dressing, or simply a body fold where skin presses against skin all hours of the day. A mid-strength cream tucked into the groin or under the breast behaves like a stronger one. So the class you read on a chart belongs to a specific product in a specific base — not to the drug name alone. When two tubes carry the same active ingredient but sit in different classes, the base and the concentration are usually the reason.

Match the strength to the body part

Skin thickness varies enormously across the body, and thin skin both absorbs more steroid and is more easily harmed by it. The eyelids, face, neck, armpits, groin, and genital skin are thin and soak up steroid quickly, so clinicians favor low-potency creams and short courses there. Palms, soles, elbows, knees, and the scalp are thick, resist absorption, and often need a higher class to work at all.

The same tube can therefore be right in one place and wrong in another. A potent cream that clears a scaly knee plaque can thin eyelid skin within weeks. This is the single most useful habit the chart teaches: before asking how strong a steroid should be, ask where it is going. The where usually settles the how strong.

Match the strength to the condition

The disease matters as much as the site. Thick, scaly plaques of psoriasis often need a potent steroid to break, and guidelines pair those steroids with steroid-sparing agents — vitamin D analogs, tazarotene, or calcineurin inhibitors — so the potent cream is not carried alone for long 1Ref 1American Academy of Dermatology; National Psoriasis Foundation (2021).Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures.Potent topical corticosteroids treat non-intertriginous psoriasis plaques and are paired with steroid-sparing agents such as vitamin D analogs, tazarotene, and calcineurin inhibitors.. Thin, inflamed conditions on the face, such as seborrheic dermatitis, are treated the opposite way: a low-potency steroid used briefly, usually alongside a topical antifungal 2Ref 2Clark GW, Pope SM, Jaboori KA (2015).Diagnosis and Treatment of Seborrheic Dermatitis.Seborrheic dermatitis is treated with topical antifungals and low-potency topical corticosteroids..

Eczema usually sits in the low-to-mid range, chosen by site and severity and layered over daily moisturizer. Coin-shaped patches are more stubborn than most people expect, and the steroid cream for nummular eczema is often a mid-potency one rather than the gentlest tube in the cabinet. The itchy, violet-colored bumps of lichen planus commonly call for a potent topical steroid, so lichen planus treatment tends to sit higher on the chart than a facial rash would.

One caution ties all of this together: a steroid is not a blind fix for any rash. The antifungal creams, weakest to strongest, are a completely different ladder, and putting a steroid on an undiagnosed fungal infection can calm the redness while letting the fungus quietly spread. That is why clinicians want to know what a rash is before choosing how strong to treat it — the diagnosis picks the class, not the other way around.

How much to use, and for how long

Two questions decide whether a steroid helps or harms: how much goes on, and how long it stays in use. The amount is usually far less than people apply — a thin film that leaves a faint sheen, not a thick, visible coat. Clinicians often teach the fingertip unit, the small ribbon squeezed along an adult fingertip, as a way to measure a consistent, modest amount instead of guessing from the tube.

Duration follows the same logic as potency. Strong classes on the face or in folds are kept to short bursts; longer courses belong to thick skin and stubborn plaques, and even those are usually stepped down or rotated with a steroid-sparing agent rather than continued indefinitely. Moisturizer is not a bystander here. Used consistently alongside active treatment, moisturizers reduce the amount of topical steroid needed and lengthen the time between flares 3Ref 3van Zuuren EJ, Fedorowicz Z, Christensen R, et al. (2017).Emollients and moisturisers for eczema.Moisturizers used with active treatment reduce the amount of topical corticosteroid needed and lengthen the time between eczema flares.. For eczema in particular, standard care is a triad: daily skin care, a topical anti-inflammatory such as a steroid or a calcineurin inhibitor, and avoiding known triggers 4Ref 4Schoch JJ, Anderson KR, Jones AE, Tollefson MM (2025).Atopic Dermatitis: Update on Skin-Directed Management: Clinical Report.Skin-directed eczema management is a triad of maintenance skin care, topical anti-inflammatory therapy (corticosteroids or calcineurin inhibitors), and trigger avoidance.. The steroid is one leg of a stool, not the whole seat.

The working rule behind the whole chart is the lowest potency that controls the problem, for the shortest time, on the thinnest skin involved.

What goes wrong when the strength is wrong

Using too strong a steroid, for too long, on thin skin is where the harms gather. The skin can thin and wrinkle (atrophy), develop stretch marks (striae) and visible fine blood vessels, and — on the central face — erupt in a persistent rash of small bumps and pustules called perioral dermatitis, a condition strongly associated with topical steroid use and treated by stopping the offending steroid 5Ref 5Searle T, Ali FR, Al-Niaimi F (2021).Perioral dermatitis: Diagnosis, proposed etiologies, and management.Perioral dermatitis is strongly associated with topical corticosteroid use and is managed by stopping the offending steroid.. The cruel part is that the steroid often calms the face at first, so it feels like the fix while it is quietly the cause; this is the cream that feeds perioral dermatitis, and the link between perioral dermatitis and steroids is one of the clearest cautionary tales on the whole chart.

Two other patterns show up with long, heavy use. Tachyphylaxis is the sense that a cream has simply stopped working. And after months of a potent steroid on the same skin, some people react when they stop — a rebound of burning, redness, and flaking known as topical steroid withdrawal, with its own topical steroid withdrawal symptoms and recovery arc worth understanding before starting a long course. Rarely, a potent steroid spread over a large area or sealed under occlusion is absorbed enough to affect the body more widely, which is why big-area, long-term use is a clinician's decision rather than a self-managed one.

Steroids on babies and on the face

Infants and facial skin are where potency is dialed down the most. A baby's skin is thin, and their skin surface area relative to body size is high, so proportionally more steroid is absorbed from the same patch. Cradle cap — infantile seborrheic dermatitis — is common, benign, and usually managed first with gentle measures like emollients, mineral oil, and soft brushing before any low-potency steroid is considered 6Ref 6American Family Physician (2007).Management of Infantile Seborrheic Dermatitis.Infantile seborrheic dermatitis (cradle cap) is benign and usually managed conservatively with emollients and gentle shampooing before low-potency topical steroids are considered..

The bigger obstacle in children is often fear of the medicine itself. Steroid phobia counseling exists because many parents, worried by stories of thinned skin, under-use appropriately chosen creams and let a flare drag on far longer than it needs to. The reassurance clinicians give is specific rather than blanket: a correctly matched low-potency steroid, used briefly on the right area, is standard care, and the question of topical corticosteroid potency for infants is exactly what the chart exists to answer. Using a steroid cream on babies is not reckless when the potency fits the skin; reaching for an adult-strength tube on a baby's face is the actual risk. The same restraint governs adult faces, which stay in the low-potency, short-course lane for the same reasons a baby's skin does.

What to ask about a steroid you've been given

A few questions turn a prescription into something you can use well. Worth asking the prescriber directly: which class this steroid is, which body areas it is meant for and which to avoid, how many days or weeks to use it before stopping or stepping down, and what to switch to for maintenance once the flare settles. Each answer maps straight onto the chart.

A brand-name tube and its generic hold the same molecule and sit in the same class, so the price gap is not a strength gap. The percentage printed on the label is only part of the story, because the base can move the same concentration up or down a class. And if a cream seems to stop working, that can mean tachyphylaxis, or it can mean the diagnosis was never quite right — either way it is a reason to be re-examined rather than to quietly reach for a stronger tube. A rash that has not budged within the window the clinician expected is information, not a signal to climb the chart alone. Used this way, the strength chart stops being a wall of drug names and becomes what it is meant to be: a map from the skin in front of you to the tube that fits it.